Stina Rudolfsson

Contact

stina.rudolfsson@umu.se

Works at

Research fellow at Department of Diagnostics and Intervention

6M, Målpunkt M31, Norrlands universitetssjukhus, TRC, våning 3 Umeå universitet, 901 85 Umeå

The TβRI promotes migration and metastasis through thrombospondin 1 and ITGAV in prostate cancer cells

Oncogene

Mu, Yabing; Wallenius, Anders; Zang, Guangxiang; et al.

A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data

European Urology, Elsevier 2022, Vol. 81, (3) : 285-293

Welén, Karin; Rosendal, Ebba; Gisslén, Magnus; et al.

High-grade tumours promote growth of other less-malignant tumours in the same prostate

Journal of Pathology, John Wiley & Sons 2021, Vol. 253, (4) : 396-403

Halin Bergström, Sofia; Rudolfsson, Stina H.; Lundholm, Marie; et al.

Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype

Neoplasia, Elsevier 2016, Vol. 18, (3) : 152-161

Halin Bergström, Sofia; Rudolfsson, Stina H.; Bergh, Anders

ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome

PLOS ONE, Public Library Science 2014, Vol. 9, (9)

Hammarsten, Peter; Winther, Johanna; Rudolfsson, Stina H; et al.

Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants

PLOS ONE, Public Library of Science 2013, Vol. 8, (11) : e77407-

Jernberg, Emma; Thysell, Elin; Bovinder Ylitalo, Erik; et al.

Att hämma tumörtillväxt

Cancerforskning på nya vägar: en bok från Forskningens dag 2013, Medicinska fakulteten vid Umeå universitet, Umeå: Umeå universitet 2013 : 69-76

Rudolfsson, Stina

Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model

BJU International, Vol. 107, (11) : 1818-1824

Johansson, Anna; Rudolfsson, Stina Häggström; Kilter, Sigrid; et al.

Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment

Neoplasia, Neoplasia press 2010, Vol. 12, (4) : 336-345

Halin, Sofia; Häggström Rudolfsson, Stina; Doll, Jennifer A; et al.

Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.

Clinical Cancer Research, Vol. 16, (4) : 1245-1255

Hammarsten, Peter; Karalija, Amar; Josefsson, Andreas; et al.

Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy

American Journal of Pathology, Vol. 177, (2) : 1031-1041

Johansson, Anna; Rudolfsson, Stina; Hammarsten, Peter; et al.

Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.

Neoplasia, Vol. 11, (2) : 177-186

Halin, Sofia; Häggström Rudolfsson, Stina; Van Rooijen, Nico; et al.

Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target.

Expert opinion on therapeutic targets, Vol. 13, (2) : 219-225

Rudolfsson, Stina Häggström; Bergh, Anders

Testosterone-stimulated growth of the rat prostate may be driven by tissue hypoxia and hypoxia-inducible factor-1alpha.

J Endocrinol, Vol. 196, (1) : 11-19

Rudolfsson, Stina Häggström; Bergh, Anders

Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats.

Prostate, Vol. 67, (6) : 573-581

Hammarsten, Peter; Rudolfsson, Stina; Henriksson, Roger; et al.

A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.

The Prostate, Vol. 67, (15) : 1664-1676

Johansson, Anna; Jones, Jonathan; Pietras, Kristian; et al.

Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.

Clinical Cancer Research, Vol. 12, (24) : 7431-7436

Hammarsten, Peter; Halin, Sofia; Wikström, Pernilla; et al.

Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.

BJU Int, Vol. 98, (3) : 661-667

Ljungberg, Börje; Jacobsen, Jan; Häggström Rudolfsson, Stina; et al.

Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats.

Endocrinology, Vol. 146, (8) : 3463-3470

Johansson, Anna; Rudolfsson, Stina Häggström; Wikström, Pernilla; et al.

Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.

Cancer Research, Vol. 64, (16) : 5664-71

Halin, Sofia; Wikström, Pernilla; Rudolfsson, Stina; et al.

Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice.

Prostate, Vol. 58, (1) : 57-65

Lissbrant, Ingela Franck; Hammarsten, Peter; Lissbrant, Erik; et al.

Hormonal regulation and functional role of vascular endothelial growth factor a in the rat testis.

Biol Reprod, Vol. 70, (2) : 340-7

Rudolfsson, Stina Häggström; Wikström, Pernilla; Jonsson, Andreas; et al.

Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma

Urological research, Springer-Verlag New York 2003, Vol. 31, (5) : 335-40

Ljungberg, Börje; Jacobsen, Jan; Häggström-Rudolfssson, Stina; et al.

Propionibacterium acnes induces chronic inflammation and precancerous epithelial lesions in the dorso-lateral prostate in rats

Bergh Drott, Johanna; Olsson, Jan; Elgh, Fredrik; et al.

Mast cell targeted therapy with imatinib mesylate or sodium cromoglycate: a novel approach to inhibit angiogenesis and prostate tumour growth

Johansson, Anna; Häggström Rudolfsson, Stina; Halin, Sofia; et al.

View publications in DiVA

Research groups

Group member

Josefsson prostate cancer group

Research projects

8 June 2020 until 31 May 2022

COVIDENZA - Prostate cancer therapy for COVID-19